CA-MRSA: Epidemiology of a Pathogen of a Great Concern by Mariana Fávero Bonesso et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
4 
CA-MRSA: Epidemiology of a  
Pathogen of a Great Concern 
Mariana Fávero Bonesso, Adilson de Oliveira and  
Maria de Lourdes Ribeiro de Souza da Cunha 
UNESP- Univ. Estadual Paulista, Department of Microbiology and Immunology 
Biosciency Institute, Botucatu-SP 
Brazil 
1. Introduction 
The emergence of community-acquired methicillin resistant Staphylococcus aureus  
(CA-MRSA) strains in individuals without traditional risk factors, has caused a drastic 
change in MRSA epidemiology since community acquired infections are etiologically caused 
by MSSA (methicillin sensitive S. aureus). Initially the most affected social groups were 
soldiers, men who have sex with men, prisoners, illicit injection drug users, and athletes; 
people with compromised skin and mucosa, poor hygiene habits and postpartum mastitis; 
Native Americans of the United States, and children due to their close contact with 
contaminated nasal secretions.  
This change in epidemiology lead to molecular studies aimed at determining pathogenicity, 
virulence, resistance to different antimicrobial classes and the behavior of these strains 
against selective pressure of the human immunological system. Associating risk factors with 
the molecular studies gave rise to Molecular Epidemiology. 
Humans are the main source of Staphylococcus spp., which can be found in the skin, throat, 
intestine and nose without causing damage to the host. In hospitals, the asymptomatic host 
can disseminate S. aureus to immunocompromised patients. Since they are ubiquitous, these 
bacteria can cause several types of infections such as: necrotizing pneumonia, skin and soft 
tissue infections, bacteremia, as well as food poisoning through enterotoxin production. 
Individuals affected by CA-MRSA strains can develop from mild to metastatic and lethal 
infections, which are directly related to the synthesis of certain toxins, antimicrobial 
resistance and individual health conditions. One of the most discussed virulence factors is 
PVL (Panton-Valentine Leukocidine). Since its first association with skin and soft tissue 
infections, PVL is now believed to contribute to the elevated virulence potential attributed to 
CA-MRSA.  
Methicillin resistance is conferred by mecA gene inserted in a mobile genomic island, the 
Staphylococcal cassette chromosomal (SCCmec). Some different SCCmec regions are 
responsible for mobility and regulation, and others for resistance to several antimicrobial 
classes. According to the presence, lack or genomic variations in these regions, the cassettes 
www.intechopen.com
 
Epidemiology Insights 
 
54
can be classified in a range from type I to XI largely used to discriminate hospital and 
community types. 
Community strains are usually more sensitive to other antimicrobial classes compared to 
multiresistant health care associated strains. In fact, CA-MRSA can be resistant to other 
antimicrobials besides beta-lactams, thus decreasing the options of drug choices. Another 
subject of concern is resistance to the drug of choice for treating MRSA, vancomycin. There 
are few antimicrobials to control the infections caused by MRSA and vancomycin is one of 
them. Reports of resistance and low level of sensitivity to this drug in health care 
environments have been reported worldwide. 
All of the issues mentioned above, underscore the importance of further research on the 
behavior of CA-MRSA at the epidemiological and molecular levels enabling establishment 
and application of preventive measures and treatment in view of infections. The present 
chapter will outline the main features of CA-MRSA and epidemiological principles involved 
in the outcome briefly described above. 
2. Resistance evolution background  
Staphylococcus spp. are gram-positive cocci, catalase positive, belonging to the family 
Staphylococcaceae and the genus Staphylococcus, which currently comprises 45 species 
(Euzéby, 2011), from which 17 species can be isolated from samples from humans. 
Staphylococcus aureus is the most important species and can be found in both healthy and 
immunocompromised individuals (Santos et al., 2007). 
The Staphylococcus genus is classified according to the synthesis of the enzyme coagulase, 
and those that synthesize are classified as coagulase-positive, represented by the species 
Staphylococcus aureus, S. intermedius, S. hyicus, S. schleiferi subspecie coagulans, S. delphine and 
S. lutrae, and in the absence of the synthesis, are represented by other coagulase-negative 
species (Baba et al., 2002). Both groups can cause infections in humans and, among them, the 
main species are: S. aureus, S. epidermidis, S. saprophyticus, S. haemolyticus, S. hominis, S. 
warneri, S. capitis, S. saccarolyticus, S. lugdunensis, S. cohnii, S. xylosus, S. simulans, S. 
auricularis, S. caprae and S. schleiferi (Layer et al., 2006). 
Humans are the main reservoir of Staphylococcus aureus, which can colonize the skin, throat, 
intestine and nasal passages without causing damage to the host. Asymptomatic carriers in 
hospitals can spread S. aureus increasing risk to immunocompromised patients (Santos et al., 
2007). This ubiquity favors the installation of various types of infections such as necrotizing 
pneumonia, skin and soft tissue infections, food poisoning bacteremia through the synthesis 
of enterotoxin (Santos et al., 2007; Cunha et al., 2006; Jarraud et al., 2002; Gandhinagar & 
Silva, 2004). 
In 1940, staphylococcal infections were treated with penicillin; however, only two years after 
its introduction, nosocomial penicillinase producing strains grew resistant to penicillin by 
the inactivation of the penicillin molecules (Mimica & Mendes, 2007). Shortly thereafter, the 
same occurred with the strains of community origin necessitating the use of alternative 
antibiotics to treat infections caused by S. aureus (Ricardo, 2004). 
In the late 1950s, in Europe, resistant nosocomial and community Staphylococcus spp. had 
penicillin resistance rates of 90% and 70%, respectively (Ricardo, 2004). This finding led to a 
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search for alternatives, and in 1959, adding the acid 6-aminopenicilanic in the penicillin 
molecule allowed for protecting the precursor of penicillin beta-lactam ring. This semi-
synthetic penicillin (Named methicillin (and the analog oxacillin, used in Brazil) proved to 
be resistant to the action of beta-lactamase. However, both were effective for a short period 
of time, and in 1961, strains resistant to semisynthetic penicillins emerged. These emerging 
new strains were named MRSA (Methicillin-Resistant Staphylococcus aureus), so far unique to 
hospital settings (Ricardo, 2004; Salgado et al., 2003). 
In the 1980s the first reports emerged of infections caused by S. aureus in patients without 
risk factors for acquisition of nosocomial MRSA (HA-MRSA), resulting in the designation of 
CA-MRSA (Community-Acquired Methicillin-Resistant S. aureus) in the 1990s when reports 
of CA-MRSA increased (Ricardo, 2004). The community-acquired infections are usually 
distinct from hospitals in terms of susceptibility and the carriage of the gene that codifies for 
the synthesis of Panton-Valentine Leukocidin (PVL) responsible for tissue invasion 
preceding the skin infections (Klevens et al., 2007). 
According to criteria, it is considered that individuals affected by CA-MRSA should not 
report previous MRSA infections; the patient must have a positive culture for MRSA 
within 48 hours after hospital admission, and must not be hospitalized in the last 12 
months, or admitted to nursing homes or homecare, and did not report undergoing 
dialysis, surgery, catheters or any prior or invasive treatment at the time of MRSA 
isolation (Salgado et al. 2003). 
The transmission of the bacteria occurs through direct contact of susceptible individuals 
with asymptomatic carriers. There are frequent reports of the spread of CA-MRSA among 
men who have sex with men, soldiers, athletes, intravenous illicit drug users, prisoners, 
people with compromised skin and mucous membranes, poor hygiene, postpartum mastitis 
(Reddy et al., 2007), Native Americans from the U.S. (Klevens et al., 2007; Stemper et al., 
2006) and among children due to the contact with contaminated nasal discharge (Klevens et 
al., 2007). 
The transmission of MRSA among family members was reported in a study with 10 families. 
Strains with PFGE ST8 (USA 300), ST59 (USA 1000), and ST80 PVL-positive were found in 
this investigation (Huijsdens et al., 2006). Lung infections caused by these strains can be 
serious because the symptoms are similar to pneumonia in children; therefore, it is 
important to consider infection by MRSA especially if there were previous reported. 
(Huijsdens et al., 2006). 
Among pathogens that can cause pulmonary infections, CA-MRSA is associated with 
pneumonia and is frequently associated with pulmonary viral coinfection. Studies indicate 
that CA-MRSA agents are commonly found in pneumonia during the influenza season, and 
about 85% of S. aureus strains isolated contained the PVL gene. In three cases of severe 
necrotizing pneumonia, strategies were carried out to prevent the synthesis of Leukocidin, 
including the administration of antibiotics such as rifampicin, linezolid and clindamycin, 
and/or applying intravenous immunoglobulin to block the lytic effect of PVL under 
polymorphonuclear cells (Rouzic et al., 2010). During the influenza season of 2006 and 2007, 
there were 51 reported cases of pneumonia in health centers caused by S. aureus, and 79% 
were MRSA. Most cases of pneumonia due to MRSA occurred during or after viral infection 
(Kallen et al., 2008). 
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The treatment of MRSA infections is variable. Within a hospital environment, there are 
several options such as linezolid, daptomycin, quinupristin/dalfopristin, but vancomycin is 
one of the most commonly used to treat several types of infections, but the emergence of 
strains resistant to this antimicrobial agent limits its use. Historically the emergence of 
vancomycin resistance occurred primarily in isolates of Enterococcus spp. in 1986 and 
reported only in 1988 in a European hospital. In 1989, in the United States, Vancomycin-
Resistant Enterococci (VRE) were detected in clinical isolates and in 1993 accounted for 7.9% 
of the enterococci samples in nosocomial environments reported by the CDC. The most 
important reservoir is the gastrointestinal tract and transmission occurs mainly through 
contact with healthcare workers, and indirectly by contaminated hands in contact with the 
hospital objects where at least one of the patients had diarrhea (Mayall, 2002). 
Vancomycin resistance in VRE is due to the presence of van genes (A to G) that encode for 
the synthesis of peptidoglycan by an alternative pathway that produces precursors ending 
in D-Ala-D-Lac or D-Ala-D-Ser instead of D-Ala-D-Ala. In S. aureus, however the main 
mechanism involved in vancomycin resistance relies on a thickened cell wall, production of 
abundant extracellular material that remains not well characterized and it ends up 
compromising the ability of division. These characteristics result in the synthesis of an 
altered peptidoglycan with an increased number of terminal D-Ala-Ala-D capable of 
binding free vancomycin in the outer cell wall, thus leading to a lower availability of the 
antimicrobial target molecule in the intracellular region. Strains of S. aureus with 
intermediate resistance to vancomycin (VISA) may contain 2 to 4 times more layers of D-
Ala-D-Ala than susceptible strains, being capable of binding to three to six times more 
vancomycin molecules. Some chromosomal changes are necessary to maintain this 
resistance , and in addition require a larger amount of precursors than normal strains, thus 
compromising their fitness in an environment free of this antimicrobial. This may explain 
the reason for the loss of the vancomycin resistance of VISA strains when they are in 
environments without antibiotics, giving rise to heteroresistant strains called hetero-VISA 
(Van Bambeke et al., 2004). 
3. MRSA colonization and decolonization 
Studies on colonization intend to elucidate the mechanism by which certain individuals are 
persistently or intermittently colonized while others are non-carriers. MRSA colonization is 
an important predisposing factor, since colonized individuals are at increased risk of 
acquiring infections (van Belkun et al., 2009). Colonization is well studied in inpatients due 
to the risk of dissemination and the fact that it can facilitate severe infections. 
Nasal colonization is the main form, and colonization can occur in other extra-nasal sites as 
in the skin, pharynx and perineum, but some sites are considered unusual such as the 
vagina, axilla and gastrointestinal tract. Studies may help to define carriers as in most cross-
sectional studies only a culture classifies individuals as carriers or not, while longitudinal 
studies usually classify three categories of carriers: intermittent, persistent or non-carriers. 
Often cultures are harvested in three different time periods to define the carriers (Werthein 
et al., 2005). A study concluded that a "culture rule" which combines qualitative and 
quantitative results of two nasal cultures with an interval of one week could accurately 
classify nasal carriage (Nouwen et al., 2004). 
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Persistent carriers are usually colonized by a single strain of S. aureus over a long period of 
time, whereas intermittent carriers may carry different strains over time (Werthein et al., 
2005). MRSA colonization in individuals in the community remains a low burden as 
demonstrated in a study of high school boys where no individuals were found colonized 
with MRSA. The fact that there were no carriers among this population may be a reflection 
of improvement in hygiene practices among these individuals due to previous reports of 
outbreaks in team sports (Lear et al., 2011). Although they did not found MRSA in the 
population, other studies have found colonization rates in individuals in the community 
ranging from 0.8 to 3% (Keuhnert et al., 2006; Salgado et al., 2003; Ellis et al., 2004). 
MRSA colonization in a hospital environment is a matter of utmost importance since it is 
characterized as a predisposing factor to infection. Nasal decolonization is usually 
performed with the application of mupirocin and is useful for reducing symptoms and its 
spread in hospital environments. However, the practice of decolonization with 
antimicrobials remains controversial because of the risk of acquiring drug resistance, which 
limits its use. Despite this risk, it is advised to perform decolonization in healthcare settings 
because of the risk of developing infections especially in individuals who are under invasive 
treatments and are immunocompromised (Coates et al., 2009). 
But how should we manage individuals living in the community who are characterized as 
persistent carriers of CA-MRSA, but show no clinical manifestations and are healthy? This is 
a controversial subject because a previous study showed that individuals might be co-
colonized with MSSA and MRSA, where the strains of MSSA have better fitness than MRSA, 
most likely due to the additional mechanism of resistance, which requires a cost in the 
feasibility and competitiveness of these strains. Thus, when decolonization is performed 
with mupirocin, both are eliminated and there will be competition, thus increasing the 
chances of colonization by resistant strains if both were competing for the same ecological 
niche (Dall'Antonia et al., 2005). Studies are needed to evaluate the cost-effectiveness of 
nasal colonization among residents in the community as a predisposition to infections, but 
there are chances of acquisition of resistant strains. 
The nasal vestibule is composed of highly keratinized cells including apocrine and 
sebaceous glands and hair follicles. These factors are poorly studied compared to the 
mucosa and its linkage to mucins. Some of the pathogen virulence factors contribute to 
successful colonization; for example, the clumping factor B is highly associated with nasal 
colonization (Wertheim et al., 2007). Studies have reported the binding of S. aureus surface 
protein G (SasG) to a ligand in nasal epithelial cells. Other factors such as: Teichoic acid and 
cell wall components recognizing microbial surface adhesive matrix molecules 
(MSCRAMMS) responsible for the adherence protein in fibronectin, fibrinogen and collagen, 
may play an important role in colonization (Wertheim et al., 2005). 
4. Case reports 
Case reports of CA-MRSA emerged worldwide revealing the severity, spread, which has 
helped to chart the epidemiologic distribution in the various communities and provide a 
better understanding of the behavior of virulence and resistance profile of these strains 
involved. Such isolates are associated with diseases of skin and soft tissue (Ribeiro et al., 
2005). The infections develop from the skin surface where they penetrate to deeper layers, 
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disrupting natural barriers (Santos et al., 2007). The characteristics of the infection have to be 
similar to those caused by MSSA (methicillin-sensitive S. aureus) (Baba et al., 2002). 
Outbreaks of infections caused by CA-MRSA are increasing worldwide among all age 
groups. Several countries reported their presence as an emerging pathogen, including  the 
United States, Australia, New Zealand, Samoa, several EU countries (Ribeiro et al., 2005) 
and South America (Brazil, Uruguay and Colombia) (Alvarez et al., 2006). In Brazil there are 
several case reports confirming the presence of this pathogen in the community involving 
cases of furunculosis (Razera et al., 2009), metastatic infections with major complications 
(Strong et al., 2008) and pneumonia (d'Azevedo et al. 2009; Gelatti et al., 2009). 
There is transmission of CA-MRSA between humans and animals, and these strains may 
carry genes codifying for Panton-Valentine Leukocidin (PVL) (Rutland et al., 2009; Van 
Duijkeren et al., 2005). A diabetic patient first diagnosed with cellulitis in the bicep region in 
December 2007 was positive for S. aureus in February 2008 from ankle biopsies and of nasal 
swab cultures; both isolates had the same profile of resistance to trimethoprim/ 
sulfamethoxazole, clindamycin, erythromycin, tetracycline and ciprofloxacin, and were, 
therefore, treated both times with vancomycin . In February 2008, his eight-year-old female 
Labrador dog had widespread cellulitis in the neck, which did not respond to treatment 
with cephalexin. Tissue, blood, and secretion cultures were carried out identifying the same 
MRSA resistance profile as the dog’s owner. Typing performed by pulsed-field isolates of 
the man and animal was inconsistent with the USA epidemic clones. A spa typing 
(staphylococcal protein A) was performed and identified as spa3, the samples were negative 
for the presence of PVL. Due to the resistance profile of isolates of the patient and his close 
relationship with the hospital, it is likely that the source of these isolates was the hospital. 
This study demonstrated that humans could be a source of multiresistant pathogenic 
microorganisms for their animals (Rutland et al., 2009). 
A case study revealed that a woman with successive complications with MRSA transmitted 
the strain to her relatives as well as her dog. Samples collected from the nose and throat of 
other asymptomatic relatives were positive for MRSA. Everyone was treated with 
rifampicin and ciprofloxacin. After six months of treatment, no new samples were recovered 
in the tests for detection of CA-MRSA among the family members and the dog (Van 
Duijkeren et al., 2005). 
CA-MRSA pneumonia can be hotbeds for metastatic infections leading to vital organ 
failure. In Sao Paulo, a previously healthy of 17-year-old patient was admitted to the 
hospital with upper respiratory infection that progressed with worsening of 
bronchopneumonia, septic shock and respiratory failure in just three days. The course of 
the infection followed with pulmonary cavitations, empyema and bronchopleural fistula 
requiring pleural drainage and tracheostomy. On the 16th day of hospitalization, the 
patient required total colectomy with ileostomy for ischemic colitis. In less than 48 hours, 
the patient had two blood cultures positive for Gram-positive cocci. Laboratory tests 
revealed MRSA with resistance to erythromycin and cefoxitin, with MIC for oxacillin of 
3µg/ml and vancomycin sensitive (2µg/mL) and teicoplamin (2mg/mL). The strain was 
sensitive to trimethoprim/ sulfamethoxazole and clindamycin. PCR analysis confirmed 
the presence of the mecA gene, SCCmec type IVa in the presence of genes for γ hemolysin, 
enterotoxin A (sea) and was negative for PVL. The treatment was maintained with 
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teicoplamin for 36 days, and from day 7 with meropenem for 14 days, showing 
progressive improvement and was discharged after 72 days from the hospital. No family 
member was colonized by CA-MRSA (d'Azevedo et al., 2009). 
The presence of CA-MRSA infections involved in high morbidity has been reported. After 
infection of traumatic injury, a 27-year-old patient, healthy and without history of 
hospitalization in the previous 12 months, was admitted to the University Hospital 
Clementino Fraga Filho (Rio de Janeiro, RJ - Brazil) and treated with ceftriaxone and 
vancomycin. The examination by transtoraxic echocardiography revealed a commitment of 
the anterior mitral valve and multiple blood cultures positive for MRSA, and molecular 
analysis detected the PVL toxin and the presence of cassette type IV. The vancomycin MIC 
performed by E-test was 2µg/mL. Removal of the spleen due to an abscess was carried out, 
and the patient had a syncope and cerebral mycotic aneurysm. The patient was discharged 
after 3 months of the treatment (Strong et al., 2008). 
Pneumonia and sepsis caused by a localized source of infection caused by CA-MRSA 
occurred in one patient in Porto Alegre, Brazil, treated at the Pediatric Emergency Room 
diagnosed with cellulitis and pneumonia. The X-ray of the lesion revealed bone 
involvement, liver and aneurysm of the pulmonary vessel. Blood culture revealed the 
presence of S. aureus resistant only to oxacillin and cefoxitin. Testing by PCR revealed the 
presence of mecA, the PVL and the cassette type IVc. The clonal profile analyzed by  
PFGE found that the strain was similar to clone OSPC. The patient remained hospitalized 
for 50 days and was discharged after treatment with clindamycin and gentamicin (Gelatti 
et al., 2009). 
Reinert et al. (2008), analyzed a culture collection grown between 1995 and 1999 and 
characterized them by PFGE (electrophoresis in pulsed-field gel). The results showed that 
the predominant profile (80%) corresponded to the Brazilian Epidemic Clone (BEC). Three 
of the 50 selected samples, harbored the cassette type IVc, and MLST (Multi Locus Sequence 
Typing) differed from each other: ST3, ST5 and ST88. These data showed that the presence 
of CA-MRSA in Brazil is longstanding and well established and must have passed 
unnoticed in clinical laboratories. It is necessary to detect and monitor these strains in the 
community and in hospitals for a better understanding of its epidemiology, as well as to 
inform public health strategies to control its spread (Reinert et al., 2008). 
Risk factors for acquisition of CA-MRSA should be evaluated due to widespread character. 
In areas of close proximity among individuals, there is a greater risk of infection by S. 
aureus. Studies with people who maintain close contacts show that poor hygiene is an 
important factor in the acquisition of Staphylococcus aureus. In addition, younger individuals 
and the obese are more prone to colonization by MRSA. The objects of common use (soap 
and towels) and the environment are related to containing outbreaks of infections with this 
pathogen (Turabelidze et al., 2006). 
Antimicrobial agents have different levels of concentration in certain sites of infection and, 
therefore, can reach subinhibitory levels during the treatment. Studies indicate that these 
levels may contribute to an increased expression of fibronectin binding proteins in samples 
having mutant genes for DNA gyrase and topoisomerase IV (grlA and gyrA, respectively) in 
MRSA strains. Bisognano et al. (1997) noted that the mutation sites that confer resistance to 
fluoroquinolones in subinhibitory concentrations of ciprofloxacin somehow increased the 
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FNB expression of genes that encode the fibronectin binding protein, but the mechanisms 
have not yet been defined. This may explain why patients who had prior use of 
ciprofloxacin have a higher likelihood of MRSA colonization. 
The colonization by CA-MRSA in adults and children differs in the profiles of resistance to 
beta-lactam antibiotics, in which it is more typical that multi-sensitive strains colonize and 
affect children. This is mainly due to different environments they attend and hygienic 
practices follow. In addition, the antibiotics used in children may differ from those 
administered to adults, thus providing a different selective pressure in the community. 
Among adults CA-MRSA strains are more frequently resistant to gentamicin, tetracycline, 
ciprofloxacin, clindamycin and erythromycin than those observed in isolates from children 
(David et al., 2006). 
One study evaluated S. aureus strains isolated from blood cultures as the type of SCCmec, 
the presence of PVL and analyzed the clonal profile by PFGE. In this study, they mainly 
included cases of HA-MRSA defined by the following isolation criterion for MRSA: must be 
isolated for 48 hours after hospital admission, previous isolation of MRSA colonized or 
infected patient during hospitalization or surgical procedures in the 12 months preceding 
the isolation, patients who  underwent installation of a catheter or invasive devices. Of all 
the samples analyzed, 65% had the cassette type IV and that PVL was present in 92% of 
these samples. The clonal profile of 92% of samples with SCCmec type IV was USA300-ST8 
(Gonzalez et al., 2006). The isolation of S. aureus resistant to methicillin with the cassette 
type IV suggests that these strains, particularly the USA300, presents an adaptation that 
expands beyond the community environment which may cause a change in the 
epidemiology of CA-MRSA. 
5. Genetic characteristics of CA-MRSA 
As a result of these observations genetic studies began focusing on molecular mechanisms 
responsible for the resistance to antibiotics and identification of MRSA strains. These strains 
had acquired and integrated into their genome harboring resistance genes, called 
Staphylococcal cassette chromosome mec (SCCmec). SCCmec present the gene responsible for 
methicillin and other beta-lactamic antibiotic resistance (mecA), and can carry genes that 
determine resistance to other classes of antibiotics. Strains related to community-acquired 
infections contain the smaller and lighter mobile element, the types and subtypes of SCCmec 
IV or V (21 to 25 kb) (Zhang et al., 2005). 
Strains of HA-MRSA carry heavier mobile elements (SCCmec I to III) because they have 
genes that encode for resistance to several antimicrobial classes (Okuma et al., 2002). The 
mobile element SCCmec is characterized by the presence of essential genetic elements: the 
mec complex (classes A to E), the ccr complex (Hanssen & Sollid, 2007), junkyard regions (J) 
(Zhang et al., 2009) and end 3' is connected to the open reading frame (ORF), orfX. The 
SCCmec is integrated into the chromosome of Staphylococcus called attBscc a specific site 
located downstream of orfX (Zhang et al., 2008). There are several types of SCCmec (I to XI) 
(IWG-SCCmec, 2011) in addition to subtypes IIA to E and the IVg to IVa (Hanssen & Sollid, 
2007). The ccr complex has five different allotypes for the ccrA and the ccrB: ccrA1 to ccrA5, 
the ccrB1 to ccrB4 and ccrB6 and ccrC1 (IWG-SCCmec, 2011). The allotypes of the SCCmec 
complexes are characterized by the presence of certain ccr genes (Ito et al., 2004). The ccrA 
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and ccrB genes encode for recombinases of the family "invertase/resolvases." These 
enzymes mediate the integration within and outside of the SCCmec thus giving mobility to 
the chromosome cassette (Zhang et al., 2005). 
The J regions encode several pseudogenes apparently with functions related to the bacterial 
metabolism (Zhang et al., 2005), and also contain genes for resistance mediated by plasmids 
or transposons to non beta-lactam antibiotics and heavy metals (Zhang et al., 2009). They are 
divided into three segments: J1, which is the region between the ccr complex the right 
chromosomal junction and the ccr gene complex; J2, between the ccr and mec regions, and J3 
which is located between orfX and mec. Variations in the J regions within the same mec-ccr 
gene complex are used for defining SCCmec subtypes. 
The SCCmec can be found in several species of Staphylococcus spp., such as S. aureus, S. 
epidermidis, S. haemolyticus, S. hominis and S. warneri (Hanssen & Sollid, 2007). The origin of 
SCCmec is unknown, and there have been no reports that any other genus than 
Staphylococcus carries the Staphylococal cassette chromosome. The presence of SCCmec type 
IV in S. epidermidis in healthy people suggests that this can be responsible for the conversion 
of CA-MSSA for CA-MRSA (Hanssen et al., 2004) where the transmission of the mobile 
element occurs mainly by transduction mediated by bacteriophages (Ito et al., 1999). 
The mecA gene codifies a penicillin binding protein PBP 2 'or 2A (Menegoto & Picoli, 2007) 
present on the outer surface of the cytoplasmic membrane (Ricardo, 2004). In susceptible 
strains, conventional PBPs have a high affinity with the beta-lactam antibiotics which 
prevents the proper formation of cell walls. However, the second PBP has low affinity to this 
class of antimicrobials, which explains resistance to antimicrobials of the group of 
methicillin (Menegoto & Picoli, 2007; Ito et al., 2001).  
The mecA gene is regulated by two genes mecI and mecR1 that have similar functions of the 
blaR1 and blaI  mechanism that regulates the production of beta-lactamase (Chambers, 1997). 
The mecA gene is regulated by a repressor mecI, a signal transducer and trans-membrane 
sensitive to the beta-lactam mecRI; both are divergently transcribed. In the absence of beta-
lactam antimicrobial, mecI represses the expression of mecA and mecRI-mecI. However in the 
presence of beta-lactam antibiotics, the mecI is cleaved autocatalytically, and a 
metalloprotease domain, located in the cytoplasmic portion mecRI, becomes active. What 
allows the mecA gene transcription and subsequent synthesis of PBP2a is the cleavage of the 
mecI by the metalloprotease and its connection on the operative region of the mecA gene 
(Berger-Bachi & Rohrer, 2002). The presence of insertion sequences IS431 and IS1272 results 
in the induction of the mecA gene (Katayama et al., 2001). 
Other resistance mechanisms have been identified in strains that lack the mecA gene, for 
example, the overproduction of beta-lactamase responsible for the inactivation of oxacillin 
or modified resistance (MOD-SA) mediated by different types of PBPs with changed 
affinities to this antibiotic. Strains with this profile are called borderline resistant (Wey et al., 
1990). 
CA-MRSA can express resistance inducible clindamycin resistance, an option for treating 
both MSSA and MRSA in particular in cases of toxic shock syndrome. In MLSBi positive 
strains (macrolide-lincosamides-streptogramin B resistance), an inducer promotes methylase 
production expressed by the gene emr and leading to the subsequent methylation of the 23S 
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ribosome unit causing an expression of the resistance to lincosamides (e.g. clindamycin). 
Phenotypically the strains are resistant to erythromycin and clindamycin sensitive, but 
when the disk of erythromycin is set at 15mm from the clindamycin disk, the clindamycin-
induced resistant strain expressed the resistance forming a D zone near clindamycin. The 
presence of the mecA gene in CA-MRSA does not fulfill the identification criteria in itself for 
the expression of the inducible clindamycin resistance (Patel et al., 2006). 
Boyle-Vavra et al. (2005) conducted a study with patients who had skin and soft tissue 
infections and another with colonized individuals with CA-MRSA, in order to test the 
resistance to various antibiotics and isolate those carrying the mecA gene. The results 
showed that 94% of the strains recovered from these infections and 85.3% of the strains that 
colonized healthy individuals showed resistance to three or more non-beta-lactam 
antibiotics. The SCCmec IV was present in 34% of the samples from individuals who had at 
least one risk factor for acquisition of MRSA and 14.7% of the isolates showed a different 
SCCmec called SCCmec VT (Boyle-Vavra et al., 2005). 
6. Detection of phenotypic resistance to oxacillin 
There are several tests that detect phenotypic resistance to oxacillin, such as the E-test with 
oxacillin agar screening test, or Kirb-Bauer disk diffusion test, cefoxitin disk diffusion, 
determining the minimum inhibitory concentration (MIC) (Felten et al., 2002), latex 
agglutination test to detect PBP2a (Bressler et al., 2005; Martins et al. 2010). 
CHROMagar is used for the cultivation of S. aureus resulting in pink-colored colonies. 
Carricajo et al. (2001) tested the sensitivity and specificity of this medium compared with 
conventional (Columbia agar with 5% horse blood and chocolate agar). The CHROMagar 
allowed 22 strains of S. aureus grown from polymicrobial samples unlike conventional 
methods. Despite the high cost, this method had a sensitivity of 98% and specificity of 100% 
(Carricajo et al., 2001). 
The latex agglutination test detects the PBP2a protein in the cell wall of staphylococci. To 
assess the effectiveness of this test, Bressler et al. (2005) compared it with PCR for mecA and 
determined the MIC of the MicroScan PC20 samples tested. The latex agglutination test had 
a 99% agreement with MicroScan; three strains that were false positive in the mecA 
agglutination had two strains that were resistant, and one presented sensitivity. The latter 
had a different aminoacid in PBP2a, the M483I that conferred susceptibile to oxacillin. This 
amino acid can increase the affinity for this antibiotic or eliminate the transpeptidase 
activity of PBP2a (Bressler et al., 2005). 
The disk diffusion test in mannitol salt agar also showed favorable results in the detection of 
oxacillin resistance and a method almost as effective as the method of disk diffusion in 
Mueller-Hinton agar (Kampf et al., 1998). 
The presence of heteroresistant strains can complicate the detection of the resistance by 
these methods due to the false-negative results. The disk diffusion test with cefoxitin is 
widely used due to the induction of mecA gene expression with the production of PBP2a, 
which promotes antibiotics in strains apparently sensitive to oxacillin (Feltenet al., 2002). 
Factors such as lower incubation temperature (30 to 35 º C), osmolarity of the medium (2-4% 
NaCl), extended incubation period and inoculum density favor the detection of 
heteroresistant strains (Camarena & Sanchez, 2009). 
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The use of cefoxitin disk diffusion to detect strains carrying the mecA gene is widely 
applied, but there are laboratories that use only the broth dilution test to determine the 
MIC of a sample. One study showed correlation of the MIC of cefoxitin in the presence of 
the mecA gene for both Staphylococcus aureus and coagulase-negative Staphylococcus testing 
three brands of Mueller-Hinton broth. After testing, the strains were sent to the CDC for 
molecular detection of the mecA gene by PCR. For mecA negative S. aureus strains the MIC 
of cefoxitin was <4ug/ml and for mecA positive the MIC was >6 or 8 µg/ml when read in 
18 hours of incubation, the result was highly sensitive and specific (99.7 and 100%). 
However, for coagulase-negative levels of cefoxitin were sensitive (at 24 hours, 94 to 99% 
for S. epidermidis and 91 to 100% non S. epidermidis), but not specific (24 hours, 85 to 91 % 
for S. epidermidis and 54 to 69% non S. epidermidis) to detect the presence of mecA 
(Swenson et al., 2009). 
Screening with oxacillin agar supplemented with 4% NaCl proposed by CLSI, as well as the 
oxacillin agar dilution and broth microdilution with 2% NaCl is used with results close to 
100% sensitivity for the detection of the mecA gene. However, when it comes to very diverse 
strains, detection of oxacillin resistance and the mecA gene are compromised, especially in 
disk diffusion testing, decreasing its specificity (classifying mecA negative strains as 
resistant) and agar screening, where low sensitivity values are obtained when more 
heterogenenous strains were tested (Swenson, 2002). 
Experiments aimed at improving identification and detection MRSA strains, particularly 
heterogeneous strains, which are more difficult to detect by conventional methods. The 
sensitivity of disk diffusion testing using 1g oxacillin disk increased from 83.5% at 35 ° C to 
91.7% when incubated at 30° C. Similarly, the sensitivity and specificity of the cefoxitin disk 
diffusion of 30 µg were 100% at a temperature of 30°C. Tests with cefoxitin are effective, 
because this antibiotic is able to detect strains inducing heterogeneous subpopulations 
expressing the mecA gene better than oxacillin. The sensitivity of the test screening at 6 µl 
oxacillin on Mueller-Hinton agar supplemented with 4% NaCl was 91.7% and specificity of 
100% in 24 hours of incubation at 35°C. The latex agglutination test for detection of PBP2a 
can reach a sensitivity of 100%, being able to identify strains with low levels of PBP2a 
(Cauwelier et al. 2004). 
Pereira et al. (2009) analyzed the sensitivity of the method of disk diffusion with oxacillin 
and cefoxitin disks, incubated for 24 h at 35°C in 100 samples of S. aureus isolated from 
pediatric and neonatal ICUs. They reported oxacillin disk sensitivity of 94.4% and specificity 
of 98%, while the cefoxitin disk presented 98% sensitivity and 100% specificity. The same 
authors also tested the screening method on Mueller Hinton agar with 6µg/ml of oxacillin 
and 4% NaCl and found a sensitivity of 98% and specificity of 100%. 
Martins et al. (2010) compared the screening methods of disk diffusion and E-test for 
detection of oxacillin resistance. They found that approximately 45% of samples were 
positive for the mecA gene, and the disk diffusion method with oxacillin disk showed a 
sensitivity of 86.9% and specificity 91.1%, respectively. The screening method showed the 
same sensitivity and specificity of 91.3%, while the E-test showed the same specificity of 
other methods and a sensitivity of 97.8% (Martin et al., 2010). 
The results found in several studies to determine the accuracy of these methods show that 
the results can vary depending on a number of factors especially the origin of the samples 
and the criteria used for its execution. 
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7. Characterization of strains of CA-MRSA 
New typing multiplex PCR protocols have been proposed, which are fast, practical and 
economical for the differentiation of clones of CA-MRSA. Some techniques are able to 
differentiate the clone of the USA 300 from the USA 400, and detects the presence of the 
gene determining resistance to oxacillin the mecA gene target of the 16S rRNA that 
distinguish Staphylococcus spp. from other bacteria, the specific nuc gene of S. aureus, the 
PVL genes and other specific genes (Zhang et al., 2008). The multiplex PCR also allows the 
detection of genes encoding toxins and chromosomal cassettes responsible for 
antimicrobial resistance in a rapid and reliable manner compared to other methods 
(Oliveira & Lencastre, 2002). 
The technique of Multilocus Sequence Typing (MLST) is widely used for typing of 
microorganisms and is based on amplification and sequencing of genes encoding proteins 
essential defining each strain based on the sequences of fragments of the seven loci of 
essential genes. As there are many allelic combinations for each of these genes, there are no 
identical profiles, and those that have, are considered members of a clone. This technique 
can be used to study evolutionary and population biology of bacteria (Enright et al., 2000). 
Strains isolated in the United States were classified as pulsed-field types (PFT's) USA300, 
USA400, USA500, USA600, USA700, USA100 and USA800, USA900, USA1000, and USA1100 
(Han et al., 2007). It is estimated that most CA-MRSA present the genetic profile of USA300, 
USA400, USA1000, and USA1100, which the predominant profile is USA300. Strains 
USA100, USA200 and USA500 are frequently associated with nosocomial infections, and 
mostly have chromosomal cassette multidrug resistance in type II (Klevens et al., 2007). 
For MRSA typing techniques based on PCR, PFGE, ribotyping and plasmid typing, are 
widely used with successful results. The considerable genetic similarity between these 
microorganisms requires the use of more than one method for identifying more accurately 
(Oliveira et al., 2001). 
spa typing involves sequencing the polymorphic region X of the gene of protein A (spa) that 
contains a variable number of repeated regions of 24 bp flanked by conserved regions as 
well. In addition to this grouping, based on the sequence of a locus, it is practical, 
inexpensive, fast, and has a lower probability of errors compared to PFGE and MLST 
techniques, and can be used in local and global epidemiological studies due to micro-and 
macro-variations that occur simultaneously in region X. The following types of protein A 
were characterized in CA-MRSA: t008, t019, t021, t044, T131, t216 (Hallin et al., 2007). 
8. The role of the Panton-Valentine Leukocidin (PVL) 
One of the most important common virulence mechanisms in CA-MRSA is PVL (Panton-
Valentine Leukocidin) production. Strains that harbor the SCCmec element may 
simultaneously carry the lukS and lukF genes wich encode for PVL (Boyle-Vavra & Daum, 
2007). Deep infections of skin and soft tissues such as skin boils and abscesses, and 
necrotizing pneumonia are attributed to the presence of PVL toxin in strains of S. aureus 
(Lina et al., 1999, Melles et al., 2006). The presence in the lungs causes hemorrhage, extensive 
necrosis of alveolar septa, destruction of the epithelium covering the bronchi and 
bronchioles (Zhang et al., 2005), and histological sections show necrotic lesions in the 
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mucosa of the trachea (Lina et al., 1999). Due to these facts, studies have proposed that the 
propensity of CA-MRSA infections cause severe skin and soft tissue lesions, and possibly 
necrotizing pneumonia, is due to the presence of the gene encoding the production of PVL 
(Saïd-Salim et al. 2005). 
PVL was first described as a "substance leukocidin" by Van deVelde in 1894 but was first 
associated with skin and soft tissue infections by Panton and Valentine in 1932. The 
acquisition of genes encoding PVL is made by transduction of a specific type of 
bacteriophage, phiSLT, which causes cytolysis in carrier gene cells and transport this gene to 
another cell. From its transcription two exoproteins , the Luks-PV and LukF-PV are 
produced, acting through the synergistic action of both subunits (Melles et al., 2006, Saïd-
Salim et al., 2005). When secreted, LukS-PV initiates a connection to the membrane of the 
polymorphonuclear leukocyte (PMN) and is dimerized with LukF-PV, alternating one and 
another until the complete formation of a heptamer. Calcium channels are formed by 
inducing the production of interleukins and inflammatory mediators. Because of this 
evidence, probably the PVL is not directly associated with tissue necrosis, but related to 
lysosomal granules released by cytotoxic lysis of PMN, the release of granulocyte reactive 
oxygen or even the inflammatory cascade (Boyle-Vavra & Daum, 2007). 
The main target of PVL is human and rabbit neutrophils, having little or no effect on non-
human primates and mice (Löffler et al., 2010). The reason for differences in sensitivities to 
PVL is not yet fully known but may be related to receptor/signal transducers that are 
species-specific (Löffler et al., 2010). Its action is directly related to the concentration: at high 
concentrations, it causes cell lysis; at low concentrations, it mediates caspase dependent 
apoptosis by forming pores in the membrane of mitochondria (Boyle-Vavra & Daum, 2007; 
Lo & Wang 2011). Sub-lytic concentrations induce apoptosis of human neutrophils within 6 
hours, and at high concentrations leads to cell death in only 1 hour (Lo & Wang, 2011). 
9. Other virulence factors of MRSA 
The pathogenicity of S. aureus depends on several determinants, among them, the 
production of toxins and extracellular membrane components (Jarraud et al., 2002; 
Gandhinagar & Silva, 2004). The molecular basis of pathogenicity of S. aureus depends on 
the expression of broad classes of accessory genes producing components of the cell wall 
and extracellular proteins. The expression of these virulence factors is regulated by genes in 
the operon agr (accessory gene regulator), which regulates the expression of genes for toxins 
and adhesins (Purcell & Fergie, 2005). Enzymes such as coagulase and catalase are 
responsible for its evasion of the immune system (Gandhinagar & Silva, 2004). 
The toxins are related to staphylococcal toxic shock syndrome (TSS), staphylococcal scarlet 
fever (both due to the toxin of toxic shock syndrome 1 [TSST-1] and staphylococcal 
enterotoxins), scalded skin syndrome (SSS due to exfoliatins) and food poisoning (SE’s, 
staphylococcal enterotoxins) (Santos et al., 2007; Jarraud et al., 2002; Johnson et al., 1991). 
Genetic sequencing of a strain called MW2, CA-MRSA, revealed the presence of genes 
responsible for specific virulence factors such as the PVL toxin, staphylococcal enterotoxin H 
(seh) and staphylococcal enterotoxin C (sec) (Saïd-Salim et al., 2005). 
Toxic shock syndrome was related primarily to the use of a particular brand of tampons in 
1980. The TSS can occur in patients of any age, with the main presenting symptoms being 
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fever, rash, and toxicity, which often progresses to hypotension with a prior history of 
watery diarrhea, sore throat, nausea, vomiting and myalgia. A number of other symptoms 
involving dehydration and its effects are often related to the syndrome. Blood cultures may 
be negative for the pathogen. The strain that carries TSST-1 reacts with phage group I and is 
likely to produce toxins, including other enterotoxins, and exoproteins. It may also exhibit 
resistance to heavy metals, and proteolytic characteristics are not often haemolytic and 
usually tend to be pigmented. It is interesting that strains produce TSST-1 positive alpha-
hemolysin in low quantities even if they have the gene, suggesting that certain genetic 
events leading to repression of some genes (e.g., hemolysin) at the same time the expression 
of other genes (i.e. TSST -1) is increased (Todd, 1988). 
Scalded skin syndrome (SSS), better known as Ritter's disease was first described by 
German physician Baron Gotfried Ritter von Rittershain who observed the widespread 
phenomenon in 297 children calling it neonatal exfoliative dermatitis. This disease usually 
appears in children with clinical features ranging from localized to disseminated bullous 
impetigo, known for easily rupturing on the skin surface, releasing a fluid with features 
ranging from thin to thick, being opaque purulent yellowish, whitish or opaque. In neonates 
lesions are mainly located in the perineum, or both in the periumbilical region, and in older 
children the lesions are located near the umbilicus. This is the mildest form of the disease, in 
which the skin around the preserved area remains without systemic signs and symptoms. 
The generalized form of the disease is mainly spread across the surface of the skin and 
mucous membranes are usually spared. In infants, onset of symptoms begins between 3 to 
16 days. Patients with systemic SSS present fever, malaise, lethargy, irritability, loss of 
appetite, followed by the appearance of erythematous papules that usually start in the head 
and neck and spread to the rest of the body in a few days (Ladhani et al., 1999). 
Another mechanism of virulence that has often been identified  in samples of CA-MRSA is 
phenol-soluble Moduline . PSM was first detected in cultures of S. epidermidis. Antimicrobial 
activity against Group A Streptococcus (Cogen et al., 2010) and activities that stimulate the 
immune system of NFkB nuclear factor kB in THP-1 cells and cytokines in THP-1 monocytes 
and its role in the infection still need to be clarified (Mehlin et al., 1999). In PVL-positive CA-
MRSA samples, the PSM effect is to intensify the effects of the toxin in the presence of both 
units (LukS-and LukF-PV) (Hongo et al., 2009). 
The detection of PSM in CA-MRSA strains was higher than in HA-MRSA strains showing 
that S. aureus PSM activate human neutrophils triggering an inflammatory response and 
thereby contributes to staphylococcal virulence. CA-MRSA PSM has an important role in 
leukocyte cytolysis by CA-MRSA primarily participating in evasion of the host defense 
system (Wang et al., 2007). 
PVL, alpha-toxin and protein A, represent the virulence factors involved in pneumonia 
caused by S. aureus. Alpha-toxins and PVL form pores in the polymorphonuclear cells and 
thus causes an exaggerated response by the release of cytokines and reactive oxygen 
specimens and contributing to damage in lung tissue (Hayashida et al., 2009). 
Studies in the United States report that the USA400 strain responsible for lethal pneumonia 
in three children, had cytotoxins, such as virulence factors alpha and gamma, PVL, phenol-
soluble Moduline (PSMs), staphylococcal enterotoxin (SE) B or C. The profile of toxigenic 
strains of USA300 is similar, except for staphylococcal-like enterotoxin (SE-l) Q present in 
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these strains. CA-MRSA USA 100 and 200 clones have emerged with alpha +/- and gamma-
toxin +/-, PVL +/- PSM+ and TSST-1+ profiles. Probably the production of several 
cytotoxins combined with superantigen action culminates in a devastating disease 
(Schlievert, 2009). 
Beta hemolysin was also related to lung injury as demonstrated by Hayashida et al. (2009). 
In this study, the hemolysin was attributed to the ability to increase the influx of neutrophils 
in the lung and alveolar spaces, causing leakage of serum proteins into the lung parenchyma 
and exudation of protein rich fluid into the air. The neutrophil migration is indirectly 
modulated by beta-hemolysin through the stimulation of other host factors. Thus, the 
virulence of hemolysin increases the regulation of various pro-inflammatory cytokines and 
generates an exaggerated response in the host (Hayashida et al., 2009) 
10. Current antimicrobial drug choice 
Given the great potential of CA-MRSA infections to develop into serious and/or systemic 
infections, there is an interest in reintroducing drugs such as trimethoprim/ 
sulfamethoxazole, tetracycline and clindamycin for treatment of CA-MRSA. In severe cases 
where there is need for hospitalization and intravenous therapy, antibiotics such as 
vancomycin, linezolid and daptomycin are reliable options (LaPlante et al., 2008). 
The combination of trimethoprim/sulfamethoxazole (cotrimoxazole) has been considered a 
good therapeutic option for the treatment of patients affected by CA-MRSA. In vitro tests 
show that it has excellent bactericidal activity, but its activity can be reduced in the presence 
of rifampicin. Several antimicrobial combinations were tested, such as linezolid and 
cotrimoxazole, rifampicin,. Cotrimoxazole, minocycline, linezolid, clindamycin  
or moxifloxacin, cotrimoxazole alone proved to be more effective in in vitro tests (Kaka  
et al., 2006). 
However, in another study with patients affected by CA-MRSA treated with 
trimethoprim/sulfamethoxazole, clindamycin and cephalexin resulted in a treatment failure 
rate of 26%, 25% and 33%, respectively. In addition, patients who received the drainage of 
abscesses in addition to antibiotic therapy had lower rates of treatment failure (25%) than 
patients who received only incision and drainage (60%) (Frei et al., 2010). 
One of the main strains in the community, the USA300 had plasmid-mediated resistance to 
tetracycline, clindamycin, and mupirocin (Han et al., 2007). In addition, there is the 
possibility of clindamycin inducible resistant strains resulting in treatment failure. In places 
where there is high frequency of isolation of strains with this characteristic, it is necessary to 
choose alternative treatments. It is estimated that this phenomenon occurs in approximately 
13% of CA-MRSA strains (LaPlante et al., 2007) and from 36% to 56% of HA-MRSA (Siberry 
et al., 2003). The treatment of clindamycin-sensitive strains was assessed showing that the 
best options were daptomycin, clindamycin, doxycycline, vancomycin, linezolid and 
trimethoprim/sulfamethoxazole, respectively, with the latter three being equally effective. 
Treatment with daptomycin was better than vancomycin and linezolid, the latter two 
having equal effect, but all three overcame the effects of clindamycin since these strains can 
show induced resistance and the treatment with clindamycin also induces the emergence of 
constitutive resistance (LaPlante et al., 2008). 
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Choosing the best option for treating infections caused by CA-MRSA has risks and benefits 
of each antimicrobial agent that must be considered before prescribing. The ideal 
antimicrobial agent would be one of low toxicity to the individual, the rapid bactericidal 
activity, excellent tissue penetration, consistent pharmacokinetics and pharmacodynamics 
that would allow a predetermined dose, low potential for development of resistance during 
therapy and a proven clinical efficacy and microbiological (Nguyen & Graber, 2010). 
Finding a single antimicrobial agent with these characteristics may be complex, whereas a 
combination of agents can be a successful alternative. 
It is not enough to choose antimicrobials with these characteristics; it is also essential to 
observe antimicrobial participation in the various mechanisms of virulence of the 
microorganism. In several reports of infections caused by CA-MRSA, PVL appears 
simultaneously as a virulence factor. The use of antimicrobials may act in the synthesis of 
Leukocidin improving the patient's condition in cases of pneumonia caused by CA-MRSA 
PVL positive strains treated with linezolid and clindamycin which suggests that this is a 
good choice, acting on the protein production mechanism, these antibiotics prevent PVL 
production compared with vancomycin and nafcillin (Stevens et al., 2007).  
11. Vancomycin resistance 
Another concern is the emergence of resistance to the antibiotic of choice for treating MRSA, 
vancomycin. Few drugs are available to control MRSA, and vancomycin is one of them. 
Reports of resistance and low sensitivity to this antibiotic are present in nosocomial 
environments worldwide (Martins & Cunha et al., 2007). 
The first case of reduced susceptibility to vancomycin was reported by Hiramatsu (1997) in a 
pediatric patient with positive culture for MRSA who was treated with glycopeptide. 
Phenotypic analysis showed that the MIC for this strain was 8 µg/mL in the microdilution 
test, and molecular analysis did not detect the presence of vanA or vanB genes. Strain Mu50, 
recovered from this patient, represents the first strain of S. aureus to demonstrate this level 
of resistance to vancomycin (Hiramatsu, 1997). 
The first report of vancomycin resistance in the U.S. was described by Sievert et al. (2002). 
The patient was treated with several courses of antibiotics including vancomycin and 
subsequently developed MRSA bacteremia due to a hemodialysis catheter. He received 
vancomycin, rifampin and required removal of this catheter. The cultures of the catheter 
revealed the presence of S. aureus resistant to oxacillin and vancomycin. After one week, 
VRSA and vancomycin-resistant Enterococcus (VRE) were isolated. Cultures did not 
recovered VRSA from the patient being treated with trimethoprim/sulfamethoxazole, 
successfully. Molecular analysis revealed the presence of the vanA gene from enterococci, 
which explains the resistance to glycopeptides, and mecA (Sievert et al., 2002). 
Cases of S. aureus with intermediate resistance to vancomycin (VISA) in addition to 
presenting heteroresistance are increasingly common in health centers where MRSA 
infections are treated with vancomycin (Trakulsomboon et al., 2001; Van Duijkeren et al., 
2005; Kim et al., 2000). 
Kim et al. (2000) observed that the vancomycin-resistant strains showed changes in the cell 
wall due to selective pressure caused by prolonged use of vancomycin in the treatment of 
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infections caused by MRSA. On the other hand, in vitro gene transfer of vanA resistance was 
observed from vancomycin-resistant Enterococcus strains to S. aureus (Sievert et al., 2002). 
The detection of resistance is a matter of controversy. Some authors Defend the idea that the 
disk diffusion method may not be effective in detecting resistance to glycopeptides, 
particularly vancomycin (Kim et al., 2000; Walsh et al., 2001). 
In San Francisco, USA, a patient with subsequent complications was initially diagnosed with 
MRSA susceptible to trimethoprim-sulfamethoxazole. A more accurate survey was 
conducted showing that the strain belonged to the PFGE USA 300-0114 of community origin 
and had intermediate resistance to vancomycin. This strain is closely related to infections of 
skin and soft tissues as well as lung disease. Surveillance in the United States in San 
Francisco shows an explosive increase of infections by USA300 CA-MRSA, can also replace 
other strains (Graber et al., 2007). 
12. Resistance in Staphylococcus spp. 
Coagulase-negative staphylococci (CoNS) are part of the microbiota of the skin, most often 
presenting a benign relationship with the host. However, they are the major opportunistic 
pathogens of immunocompromised patients in hospitals (Bisno & Stevens, 1996; Cunha et 
al., 2004). Important infectious processes related to CoNS have been reported in recent 
decades. They are commonly isolated from blood cultures of patients undergoing invasive 
procedures such as prostheses, catheters, organ transplants, as well as from premature 
infants (Cunha et al., 2004). 
The main species of CoNS that are involved in infections in humans are S. epidermidis (may 
cause bacteremia, osteomyelitis, peritonitis, surgical site infections, infections due to the 
installation of catheters and prostheses, endophthalmitis, etc.), S. haemolyticus (urinary tract 
infection, peritonitis, injuries, etc.) and S. saprophyticus (urinary tract infection and 
septicemia) (Cunha et al., 2004). Specifically regarded to the occurrence of bacteremia in 
hospitals, the species S. epidermidis was found to be the etiologic agent in 80% of cases 
(Gongora-Rubio et al., 1997). 
Resistance to methicillin in species of CoNS (MRSCoN) colonizing healthy individuals can 
overcome MRSA in the same population as demonstrated by a Japanese study (Hisato et 
al., 2005). Analysis of 818 children revealed that 35 (4.3%) carried MRSA, while 231 
(28.2%) MRSCoN. The fact that MRSCoN strains are prevalent in the community suggests 
that they are important reservoirs of SCCmec that can be carried to strains of S. aureus 
(Hisato et al., 2005). 
Strains of vancomycin-resistant CoNS are common in hospitals due to this antibiotics’ 
selective pressure in this environment, but few studies have been published on this 
community. A surveillance study assessed the cultures of saliva collected from employees of 
a private school and 37 hospital staff. The identification of specimens recovered from 
samples revealed that 98.5% were carriers of Staphylococcus spp. and 76.5% were carriers of 
more than one Staphylococcus spp. species. Four strains were resistant to vancomycin 
according to phenotypic tests isolated from two school officials and two hospital employees, 
and two identified as S. capitis and the other two as S. haemolyticus and S. epidermidis. All 
samples carried the mecA gene of resistance to oxacillin and were negative for the genes 
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vanA, vanB and vanC. The samples relating to employees of the hospital were also resistant 
to other classes of antimicrobials (Palazzo et al., 2005). 
MRSCoN may be involved in severe infections and present different resistances, as well as 
virulence factors able to offer health risks of individuals with impaired immune systems or 
in development as in the case of neonates. Despite its great importance in critically ill 
patients, its presence in healthy individuals deserves special attention mainly because they 
are both sources of genes for virulence and resistance. 
13. Future prospects 
The emergence of S. aureus resistant to methicillin in the community as the main agent of 
serious infections of skin and soft tissue is disturbing since oxacillin would be the drug of 
choice to treat infections caused by strains resistant to other antibiotics. Several techniques 
can be used to detect resistance to oxacillin, but PCR is the safest and most effective. In 
addition to PCR, other techniques allow genetic characterization of CA-MRSA detailing an 
arsenal of toxins and differentiation of clones involved in outbreaks. These techniques help 
epidemiologist determine correct measures in controlling the spread of this pathogen. 
Studies in Epidemiology associated with molecular studies represent good tools for 
understand the distribution and inform treatment success. The detection of antimicrobial 
resistance in strains from patients living in the community reveals that the alternatives 
available to the medical community for successful treatment are decreasing gradually, thus, 
presenting an opportunity to research new drugs, and antimicrobial agents considered older 
and well established such as trimethoprim/sulfamethoxazole, which is re-emerging as an 
option for treating infections caused by CA-MRSA. 
The presence of CA-MRSA strains involved in nosocomial infection implies the need for 
greater control of its spread among hospitalized patients, since the reports of strains of 
community origin suggest they are also more virulent compared to strains of nosocomial 
origin, and may lead to serious complications of rapid evolution. Treatment strategies that 
may delay or prevent the expression of these factors will need to be established, as well as 
administering the correct treatment quickly and effectively. 
14. Conclusion 
The presence of resistant strains in the community, especially S. aureus, poses a risk to public 
health since the treatment may fail, delaying the elimination of pathogens involved in these 
infections. This delay can result in serious complications leading to early death of the 
patient. New treatment alternatives and the rediscovery of antimicrobials that are no longer 
being used provide to the medical community a new opportunity for successful treatment. 
In addition to antimicrobial resistance, community strains have become more virulent, 
which provides another challenge to the attending physician to choose the best treatment 
strategy possible. Attention should also be directed to CoNS strains resistant to methicillin, 
which can serve as reservoirs of resistance genes S. aureus that are more virulent. The 
detections of virulence factors and antimicrobial additional resistance can be truly 
challenging and lead to treatment failure if it is not detected quickly. Fortunately there are 
new approaches that are becoming affordable to microbiology laboratories that can detect as 
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far as the patient is attended. But to reach the 100% of the treatment success it will need 
more than top notch technologies. 
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